Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: American Spirit who wrote (45711)	1/17/2001 5:45:35 PM
From: HandsOn	Read Replies (1) \| Respond to of 57584

First call says loss of AAPL was .73, est was .65.

To: American Spirit who wrote (45711)	1/17/2001 11:12:52 PM
From: DlphcOracl	Respond to of 57584

Here's an idea for the thread. It seems that when the techs rally, a lot of the money comes from the healthcare sector as it rotates out of last year's winner to ride the perceived tech momentum. This creates some nice buying opportunities in selected healthcare stocks. These stocks will come back into favor from mid-March through October when the techs retrace the Q1 gains. I would specifically recommend looking at: Quest Diagnostics (DGX) and Laboratory Corp. of America (LH). Both are stocks on Louis Navellier's Buy List, with excellent earnings and nice market niche. They are both "picks-and-shovel" plays in the healthcare/biotech sector. One caveat: they may still be falling and seeking a new base. You may want to continue tracking these until you are comfortable with entry price. Both are currently off 25-30% this year alone, based primarily on rotation from healthcare sector into tech sector (IMO).